Effects of a nutrient mixture on infectious properties of the highly pathogenic strain of avian influenza virus A/H5N1

BioFactors

Volumn 33, Issue 2, 2008, Pages 85-97

  Deryabin, Petr G ^b   Lvov, Dmitry K ^b   Botikov, Andrey G ^b   Ivanov, Vadim ^c   Kalinovsky, Tatiana ^c   Niedzwiecki, Aleksandra ^a,c   Rath, Matthias ^c  

^a DI Ivanovsky Research Institute on Virology ^*  (United States)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c Dr Rath Research Institute   (United States)

Author keywords

Antiviral activity survival; Avian influenza virus A H5N1; Cell cultures; Cytotoxicity; Nutrient mixture

Indexed keywords

ACETYLCYSTEINE; AMANTADINE; ASCORBIC ACID; GREEN TEA EXTRACT; LYSINE; OSELTAMIVIR; PROLINE; SELENIUM;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; NONHUMAN; NUTRIENT CONTENT; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; ASCORBIC ACID; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; LYSINE; MICRONUTRIENTS; PLANT EXTRACTS; PROLINE; SELENIUM; TEA; VERO CELLS;

ANAS; AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 65949112682     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520330201     Document Type: Article

References (42)

1. E.K. Barbour, E.G. Rayya, H. Shaib, R.G. El Hakim, A. Niedzwiecki, A.M.A. Nour and S. Harakeh, Rath M. Evaluation of the efficacy of Epican Forte against avian flu virus, Intern J Appl Res Vet Med 5 (1) (2007), 9-16.
2. M. Beck, H. Nelson, K. Shi, P. Van Dael, E. Schiffrin, S. Blum, D. Barclay and O.A. Levander, Selenium deficiency increases the pathology of an influenza virus infection, The FASEB J 15 (2001), 1481-1483.
3. R.B. Belsche, The origins of pandemic influenza - Lessons from the 1918 virus, NEJM 353 (2005), 2209-2211.
4. P.G. Deryabin, D.K. L'vov, E.I. Isaeva, G.A. Danlybaeva, R.Y. Podcherniaeva and M.Y. Shchelkanov, The spectrum of vetebrates' cell lines sensitive to highly pathogenic influenza A/tern/SA/61 (H5N3) and A/duck/Novosibirsk/56/05 (H5N1) viruses, Vopr Virusol 52(1) (2007), 45-47, Russian.
5. R. Dolin, R.C. Reichman, H.P. Madore, R. Maynard, P.N. Linton and J. Webber-Jones, A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection, NEJM 307 (1982), 580-584.
6. T.M. Ellis, R.B. Bousfield, L.A. Bissett, K.C. Dyrting, G.S. Luk, S.T. Tsim, K.M. Strum-Ramirez, R.G. Webster, Y. Guan and J.S.M. Peiris, Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002, Avian Pathol 33(5) (2004), 492-505.
7. G. Fassina, A. Buffa, R. Benelli, O.E. Varnier, D.M. Noonan and A. Albini, Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent, AIDS 16 (6) (2002), 939-941.
8. A.S. Gambaryan, A.B. Tuzikov, N.V. Bovin, S.S. Yamnikova, D.K. L'vov, R.G. Webster and M.N. Matrosovich, Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong, Avian Dis 47 (suppl 3) (2003), 1154-1160.
9. C.S. Ghandi, K. Shuck, J.D. Lear, G.R. Dieckmann, W.F. De Grado and R.A. Lamb, Cu(II) inhibition of the proton translocation machinery of the influenza A virus by gentian violet (GV) and GV-dyed cotton cloth, and bacteriological activities of these agents, J Infect Chemother 12 (1999), 73-79.
10. P. Ghezzi and D. Ungheri, Synergistic combination of N-acetyl cysteine and ribavirin to protect from lethal influenza viral infection in a mouse model, Int J Immunopathol Pharmacol 17 (2004), 73-79.
11. S. Harakeh, R.J. Jariwalla and L. Pauling. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells, PNAS 87 (18) (1990), 7245-7249.
12. F.G. Hayden, R.L. Atmar, M. Schilling, C. Johnson, D. Poretz, D. Paar, L. Huson, P. Ward and R.G. Mills, Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza, NEJM 341 (1999), 1336-1343.
13. T. Hennet, E. Peterhans and R. Stocker, Alterations in antioxidant defenses in lung and liver of mice infected with influenza A virus, J Gen Virol 73(1) (1992), 39-46.
14. N. Imanishi, Y. Tuji, Y. Katada, M. Maruhashi, S. Konosu, N. Mantani, K. Terasawa and H. Ochiai. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells, Microbiol Immunol 46 (2002), 491-494.
15. T. Ito, J.N. Couceiro, S. Kelm, L.G. Baum, S. Krauss, M.R. Castrucci, I. Donatelli, H. Kida, J.C. Paulson, R.G. Webster and Y. Kawaoka, Molecular basis for the generation in pigs of infleunza A viruses with pandemic potential, J Virol 72 (1998), 7367-7373.
16. V. Ivanov, M.W. Roomi, T. Kalinovsky, A. Niedzwiecki and M. Rath, Anti-atherogenic effects of a mixture of ascorbic acid, lysine, proline, arginine, cysteine and green tea phenolics in human aortic smooth muscle cells, J Cardiovasc Pharmacol 49 (3) (2007), 140-145.
17. R.J. Jariwalla, M.W. Roomi, B. Gangapurkar, T. Kalinovsky, A. Niedzwiecki and M. Rath, Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a nutrient mixture containing ascorbic acid, green tea extract and amino acids, Biofactors (in press).
18. T. Jefferson, V. Demicheli, D. Rivetti, M. Jones, C. Di Pietrantonj and A. Rivetti. Antivirals for influenza in healthy adults: systematic review, Lancet 367(9507) (2006), 303-13, Review. Erratum in: Lancet 367(9528) (2006) 2060.
19. S. Kawakami, Y. Kageyama, Y. Fujii, K. Kihara and H. Oshima, Inhibitory effects of N-acetyl cysteine on invasion and MMP 9 production of T24 human bladder cancer cells, Anticancer Res 21 (2001), 213-219.
20. Y. Kawakoa and R.G. Webster, Molecular mechanism of acquisition of virulence in influenza virus in nature, Microb Pathog 8 (1988), 311-318.
21. A.P. Kendal, Epidemiologic implications of changes in influenza virus genome, Am J Med 82 (1987), 4-14.
22. D.K. L'vov, M.Y. Shchelkanov, P.G. Deriabin, E.L. Burtseva, I.V. Galkina, T.V. Grebennikova, A.G. Prilipov, E.V. Us-achev, O.V. Liapina, O.V. Shliapnikova, A.B. Poglazov, A.A. Slavskii, T.N. Morozova, A.V. Vasil'ev, A.D. Zaberezhnyi, D.F. Dzharkenov, F.B. Gabbasov, M.I. Evdokimova, T.I. Aliper, K.E. Litvin, V.L. Gromashevskii, N.A. Vlasov, K.B. Iashkulov, A.I. Kovtunov, G.G. Onishchenko, E.A. Nepoklonov and D.L. Suarez, Highly pathogenic influenza A/H5N1 virus-caused epizooty among mute swans (Cygnus olor) in the lower estuary of the Volga River (November 2005), Vopr Virusol 51(3) (2006), 10-16, Russian.
23. D.K. L'vov, A.G. Prilipov, M.Y. Shchelkanov, P.G. Deriabin, A.A. Shilov, T.V. Grebennikova, G.K. Sadykova and O.V. Liapina, Molecular genetic analysis of the biological properties of highly pathogenic influenza A/H5N1 virus strains isolated from wild birds and poultry during epizooty in Western Siberia (July 2005) Vopr Virusol 51(2) (2006), 15-19, Russian.
24. D.K. L'vov, M.Y. Shchelkanov, P.G. Deriabin, T.V. Grebennikova, A.G. Prilipov, E.A. Nepoklonov, G.G. Onishchenko, N.A. Vlasov, T.I. Aliper, A.D. Zaberezhnyi, D.E. Kireev, O.P. Krasheninnikov, S.T. Kiriukhin, E.I. Burtseva and A.N. Slepushkin, Isolation of influenza A/H5N1 virus strains from poultry and wild birds in West Siberia during epizooty (July 2005) and their depositing to the state collection of viruses (August 8, 2005), Vopr Virusol 51(1) (2006), 11-14, Russian.
25. D.K. L'vov, M.Y. Shchelkanov, P.G. Deriabin, I.T. Fediakina, E.I. Burtseva, A.G. Prilipov, D.E. Kireev, E.V. Usachev, T.I. Aliper, A.D. Zaberezhnyi, T.V. Grebennikova, I.V. Galkina, A.A. Slavskii, K.E. Litvin, A.M. Dongurool, B.A. Medvedev, M.D. Dokperool, A.A. Mongush, M.S. Arapchor, A.O. Kenden, N.A. Vlasov, E.A. Nepoklonov and D. Suarez, Isolation of highly pathogenic avian influenza (HPAI) A/5H5N1 strains from wild birds in the epizootic outbreak on the Ubsu-Nur Lake (June 2006) and their incorporation to the Russian Federation State Collection of viruses (July 3, 2006), Vopr Virusol 51(6) (2006), 14-18, Russian.
26. D.K. L'vov, I.T. Fediakina, M.Y. Shchelkanov, A.G. Prilipov, P.G. Deriabin and G.A. Galegov, In vitro effects of antiviral drugs on the reproduction of highly pathogenic influenza A/H5N1 virus strains that induce epizooty among poultry in the summer of 2005, Vopr Virusol 51(2) (2006), 20-22, Russian.
27. Ministry ofPublic Health ofRussian Federation, Handbook of Experimental Studies of New Pharmacological Substances, 2005.
28. M. Morini, T. Cai, M.G. Aluigi, D.M. Noonan, L. Masiello, S. De Flora, F. D'Agostini, A. Albini and G. Fassina, The role of the thiol N-acetyl cysteine in the prevention of tumor invasion and angiogenesis, Int J Biol Markers 4(1999), 268-271.
29. A. Moscona, Oseltamivir-resistant influenza? Lancet 364 (2004), 733-734.
30. A. Moscona, Neuraminidase inhibitiors for influenza, NEJM 353 (2005), 1363-1373.
31. M. Nakayama, K. Suzuki, M. Toda, S. Okubo, Y. Hara and T. Shimamura, Inhibition of the infectivity of influenza virus by tea polyphenols, Antivir Res 21 (1993), 289-299.
32. M. Rath and L. Pauling, Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs, Orthomolecular Medicine 7 (1992), 17-23.
33. LJ. Reed and H. Muench, A simple method of estimating fifty percent endpoints, Am J Hyg 27 (1938), 493-497.
34. M.W. Roomi, V. Ivanov, T. Kalinovsky, A. Niedzwiecki and M. Rath, Inhibition of pulmonary metastasis of melanoma B16FOcells in C57BL/6 mice by a nutrient mixture consisting of ascorbic acid, lysine, proline, arginine and green tea extract, Exp Lung Res 32(10) (2006), 517-530.
35. M.W. Roomi, N. Roomi, T. Kalinovsky, A. Niedzwiecki and M. Rath, Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis, Onc Rep 14(4) (2005), 807-815.
36. M.W. Roomi, V. Ivanov, S.P. Netke, A. Niedzwiecki and M. Rath, Serum markers of the liver, heart, and kidney and lipid profile and histopathology in ODS rats treated with nutrient synergy, J Am Coll Nutr 22(5) (2003), 477, Abstract #86.
37. J.M. Song, K.H. Lee and B.L. Seong, Antiviral effect of catechins in green tea on influenza virus, Antivir Res 68 (2005), 66-74.
38. D. Ungheri, C. Pisani, G. Sanson, A. Bertani, G. Schioppacassi, R. Delgado, M. Sironi and P Ghezzi, Protective effect ofN-acetyl cysteine in a model of influenza infection in mice, Int J Immunopathol Pharmacol 13 (2000), 123-128.
39. M.E. Woolhouse and S. Gowtage-Seqeria, Host range and emerging and reemirging pathogens, Emerg Infect Dis 11 (2000), 1842-1847.
40. World Health Organization: Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO http://www.who.int/csr/disease/avian- influenza/country/cases-table-2007-11-12/en/index.html.
41. SJ. Yeo, SJ. Kim, J.H. Kim, HJ. Lee and YH. Kook, Influenza A virus infection modulates the expression of type IV collagenases in epithelial cells, Arch Virol 144 (1999), 1361-1370.
42. S.O. Yoon, M.M. Kim and A.S. Chung, Inhibitory effects of selenite on invasion of HT 1080 tumor cells, J Biol Chem 276 (2001), 20085-20092.